Extendicare (TSE:EXE) Issues Quarterly Earnings Results

Extendicare (TSE:EXE) posted its earnings results on Thursday. The company reported C$0.32 EPS for the quarter, FiscalAI reports. Extendicare had a net margin of 6.99% and a return on equity of 45.35%. The company had revenue of C$611.04 million during the quarter.

Extendicare Price Performance

Shares of Extendicare stock traded down C$0.72 during trading on Thursday, hitting C$34.19. 508,774 shares of the company’s stock traded hands, compared to its average volume of 380,956. The company has a market cap of C$3.24 billion, a PE ratio of 25.16 and a beta of 1.59. The firm’s fifty day moving average price is C$35.20 and its 200 day moving average price is C$30.10. Extendicare has a twelve month low of C$12.37 and a twelve month high of C$39.14. The company has a debt-to-equity ratio of 82.55, a current ratio of 1.44 and a quick ratio of 0.98.

Extendicare Dividend Announcement

The firm also recently announced a monthly dividend, which will be paid on Monday, August 17th. Stockholders of record on Monday, August 17th will be given a dividend of $0.0441 per share. This represents a c) annualized dividend and a dividend yield of 1.5%. The ex-dividend date is Friday, July 31st. Extendicare’s payout ratio is 37.24%.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on the stock. BMO Capital Markets lifted their price objective on shares of Extendicare from C$30.00 to C$38.00 in a research note on Wednesday, May 13th. Canaccord Genuity Group raised shares of Extendicare to a “strong-buy” rating in a research report on Monday, May 11th. National Bank Financial raised their target price on Extendicare from C$34.00 to C$40.00 and gave the company an “outperform” rating in a report on Wednesday, May 27th. Desjardins set a C$34.50 price target on Extendicare and gave the stock a “buy” rating in a research report on Wednesday, April 22nd. Finally, TD upped their price target on Extendicare from C$32.00 to C$39.00 and gave the stock a “buy” rating in a research note on Monday, May 11th. Two investment analysts have rated the stock with a Strong Buy rating and six have issued a Buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Buy” and an average price target of C$32.56.

Extendicare Company Profile

Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.